ADAGIO THERAPEUTICS, INC.
303 Wyman Street, Suite 300
Waltham, MA 02451
August 3, 2021 | Via Edgar |
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Tara Harkins |
Al Pavot |
Abby Adams |
Irene Paik |
| RE: | Adagio Therapeutics, Inc. |
Registration Statement on Form S-1 |
File No. 333-257975 |
Acceleration Request |
Requested Date: August 5, 2021
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) to become effective on August 5, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Erika Kaneko, counsel to the Registrant, at (212) 479-6454.
Very truly yours,
Adagio Therapeutics, Inc. |
/s/ Jane Henderson |
Jane Henderson Chief Financial Officer |
| cc: | Divakar Gupta, Cooley LLP |
Courtney Tygesson, Cooley LLP |
